NovoCure Limited (NASDAQ:NVCR) Q3 2023 Earnings Call Transcript October 26, 2023
NovoCure Limited beats earnings expectations. Reported EPS is $-0.46, expectations were $-0.52.
Operator: Welcome to the NovoCure Q3 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Ingrid Goldberg. Please go ahead.
Ingrid Goldberg: Good morning and thank you for joining us to...
